Human Papillomavirus Self-Sampling Attitudes Amongst Women Living with HIV Prior to a Self-Sampling Intervention
<b>Background/Objectives</b>: Our objective was to determine the acceptability of and attitudes towards HPV self-sampling among women with HIV and investigate any associations between self-sampling attitudes and participant demographic and clinical characteristics. <b>Methods:</b> Women with HIV aged 18-45 were given a description of HPV self-sampling and instructions on how to self-collect the sample. Participants completed a questionnaire assessing their perceptions of the acceptability and comfort of HPV self-sampling before using the self-sampling methodology. Responses were based on a 5-point Likert scale (strongly agree to strongly disagree) for each statement. Participants' characteristics were included in bivariate analysis. Chi-square and Fisher's exact tests were used to assess associations between questionnaire results and participant characteristics. <b>Results</b>: Of the 117 completed questionnaires, 79.6% of participants had a CD4+ T cell count ≥ 500 cells/mm<sup>3</sup>. Participants' median age was 39 (IQR 34-43). One hundred participants (85.5%) felt confident they could collect their samples correctly, and 77.8% did not think they would experience difficulties with self-collection. Most participants (68.4%) preferred to self-collect their sample instead of provider-collected sampling. Ninety-six participants (82.1%) agreed they would likely use self-collection methods for future cervical screening. Many participants were concerned about receiving a positive HPV result (68.4%), passing HPV on to their partner(s) (75.7%), and disclosing their HPV status to friends/family (49.6%). <b>Conclusions</b>: Women with HIV seem to be accepting of HPV self-sampling as a cervical cancer screening methodology; however, many participants were concerned about the implications associated with a positive HPV test result.
Authors
- Sharon Walmsley (ORCID: https://orcid.org/0000-0002-3959-5692)
- Elisabeth McClymont (ORCID: https://orcid.org/0000-0002-6869-2870)
- Deborah Money (ORCID: https://orcid.org/0000-0003-4411-7473)
- Isabelle Boucoiran (ORCID: https://orcid.org/0000-0001-9545-6024)
- Sean Yaphe (ORCID: https://orcid.org/0000-0001-8799-4703)
- Marie-Louise Vachon (ORCID: https://orcid.org/0000-0002-2182-8451)
- Valérie Martel‐Laferrière (ORCID: https://orcid.org/0000-0001-7973-8582)
- Mark H. Yudin (ORCID: https://orcid.org/0000-0002-7540-8487)
- Gina Ogilvie (ORCID: https://orcid.org/0000-0001-5783-4493)
- Vanessa Poliquin (ORCID: https://orcid.org/0000-0003-0526-3902)
- Alexander Wong (ORCID: https://orcid.org/0000-0001-5729-5899)
- Emma Karlsen (ORCID: https://orcid.org/0009-0004-2124-6525)
- Shariq Haider (ORCID: https://orcid.org/0000-0002-3776-5926)
- Sofia Nicolls
Institutions
- St. Michael's Hospital (CA)
- University Health Network (CA)
- University of British Columbia (CA)
- Regina Qu'Appelle Health Region (CA)
- University of Toronto (CA)
- McGill University Health Centre (CA)
- Centre Hospitalier Universitaire Sainte-Justine (CA)
- Health Sciences Centre (CA)
- University of Saskatchewan (CA)
- Centre hospitalier de l'Université Laval (CA)
- Women's Health Research Institute (CA)
- Centre Hospitalier de l’Université de Montréal (CA)
- Université Laval (CA)
- University of Manitoba (CA)
- McGill University (CA)
- Université de Montréal (CA)
- McMaster University (CA)
Publication Details
- Journal
- Cancers
- Published
- 2025-12-19
- DOI
- https://doi.org/10.3390/cancers18010014
- Primary Topic
- Cervical Cancer and HPV Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Université Laval
- Hamilton Health Sciences
- University of Ottawa
- McGill University
- McGill University Health Centre
- Michael Smith Health Research BC
- Université de Montréal
- Centre hospitalier universitaire Sainte-Justine
- Merck Canada
- British Columbia Centre for Disease Control
- Canadian Institutes of Health Research
- BC Cancer Agency